US Drug Recall Register
Class III · Low risk Ongoing Initiated Sep 12, 2025 (12 months ago)

Cetirizine Hydrochloride Tablets USP 10 mg, 500 Tablets bottles, Manufactured by: Unique…

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Tablet/Capsules Imprinted with Wrong ID

What was recalled

Cetirizine Hydrochloride Tablets USP 10 mg, 500 Tablets bottles, Manufactured by: Unique Pharmaceuticals Labs, (A Div. of J.B. Chemicals & Pharmaceuticals, Ltd.), Mumbai 400 030, India. Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, NDC 16571-402-50

Recalling firm
JB Chemicals and Pharmaceuticals Ltd
NDC code
16571-402-50
Origin
India
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0033-2026

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Chloride recalls

See all